GO:0043627 response to estrogen: Cellular Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043627 response to estrogen describes any cellular or organismal process that changes state or activity in response to estrogen, a C18 steroid hormone.
• Estrogen signaling regulates gene expression, metabolism, and cell proliferation, with effects observed in reproductive tissues, bone, and brain [1,5,6].
• The process is mediated primarily by estrogen receptors (ERα and ERβ), which act as ligand-activated transcription factors and also have non-genomic actions [4,7].
• Dysregulation of response to estrogen is implicated in breast cancer, osteoporosis, and age-related cognitive decline [2,5,6].
• Research methods include transcriptomics, spatial single-cell analysis, and in vitro reporter assays to dissect estrogenic responses [2,3].
• CRISPR-based models (knockout, knock-in, overexpression) enable causal testing of genes involved in estrogen response [2,4].
Description
Response to estrogen (GO:0043627) is a fundamental biological process that encompasses the diverse cellular and physiological changes triggered by estrogen, a class of C18 steroid hormones that stimulate the development of female sexual characteristics. Estrogen exerts pleiotropic effects on reproduction, metabolism, bone homeostasis, and brain function, and its actions are critical for both normal physiology and disease pathogenesis [1,5,6]. Understanding how cells sense and respond to estrogen is essential for deciphering hormone-dependent cancers, metabolic disorders, and age-related diseases [2,4]. The process involves both genomic and non-genomic signaling pathways, primarily through estrogen receptors (ERα and ERβ), which regulate gene expression and rapid signaling cascades [4,7]. This article synthesizes authoritative GO annotations and verified literature to provide a research-grade overview of response to estrogen, its molecular players, and experimental approaches for studying it.
response to estrogen At A Glance
| GO ID | GO:0043627 |
|---|---|
| GO term | response to estrogen |
| Ontology | biological_process |
| Synonym | response to 17alpha-ethynylestradiol; response to estrogen stimulus; response to oestrogen stimulus |
| Major function | Cellular and organismal changes triggered by estrogen, including gene expression, proliferation, and metabolic shifts |
| Key receptors | Estrogen receptor alpha (ESR1) and beta (ESR2) |
| Associated diseases | Breast cancer, osteoporosis, cognitive decline |
| Research methods | Transcriptomics, single-cell spatial analysis, reporter assays, CRISPR models |
What Is GO:0043627?
According to the Gene Ontology, response to estrogen (GO:0043627) is defined as any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, a C18 steroid hormone that can stimulate the development of female sexual characteristics. This broad definition includes rapid non-genomic effects and long-term genomic responses, and it applies across diverse cell types and tissues.
Why Is response to estrogen Important in Cell Biology?
Response to estrogen is central to reproductive biology, bone health, cardiovascular function, and neuroprotection, and its dysregulation underlies major human diseases such as breast cancer and osteoporosis [2,5,6]. Elucidating the molecular mechanisms of estrogen response provides insights into hormone therapy, endocrine disruptors, and personalized medicine [3,8].
• Regulates gene expression programs in reproductive tissues and beyond.
• Modulates bone remodeling and calcium homeostasis, impacting osteoporosis risk.
• Influences hippocampal plasticity and cognitive function, with age-dependent effects.
• Plays a role in exercise metabolism and performance across the menstrual cycle.
• Mediates effects of endocrine-disrupting chemicals on genomic stability.
• Involved in tamoxifen and other ER antagonist responses in breast cancer.
• Regulated by ERK1/2-RSK signaling, linking estrogen homeostasis to kinase pathways.
• Serves as a target for in vitro screening of (anti)estrogenic compounds.
What Happens During response to estrogen?
Estrogen Binding and Receptor Activation
In simple terms: Estrogen binds to its receptor, changing the receptor's shape so it can act in the cell.
Estrogen diffuses into cells and binds to estrogen receptors (ERα and ERβ), inducing conformational changes that promote receptor dimerization and activation [4,7]. This ligand-receptor interaction is the first step in the response to estrogen and can occur in the cytoplasm or nucleus.
Genomic Signaling and Gene Expression
In simple terms: Activated receptors enter the nucleus and turn genes on or off.
Activated estrogen receptors translocate to the nucleus, bind estrogen response elements (EREs) in DNA, and recruit coactivators or corepressors to modulate transcription of target genes [2,7]. This genomic pathway leads to long-term changes in cell behavior, such as proliferation and differentiation.
Non-Genomic Signaling and Rapid Effects
In simple terms: Estrogen can also trigger fast signals at the cell membrane without directly affecting genes.
Membrane-associated estrogen receptors activate kinase cascades, including ERK1/2 and RSK, leading to rapid cellular responses such as altered enzyme activity and secretion. These non-genomic effects can influence estrogen homeostasis and crosstalk with growth factor signaling.
Tissue-Specific and Context-Dependent Outcomes
In simple terms: The same estrogen signal can do different things in different tissues.
The outcome of estrogen response varies by tissue, developmental stage, and physiological state, as seen in hippocampal plasticity differences between young and aged female rats and in bone metabolism in postmenopausal women. This context dependence is critical for understanding disease-specific effects [2,5].
Key Genes Involved in GO:0043627 response to estrogen
The following genes and proteins are central to the response to estrogen, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESR1 | Estrogen receptor alpha; mediates genomic and non-genomic estrogen signaling | Breast cancer, osteoporosis, hormone therapy [2,7] |
| ESR2 | Estrogen receptor beta; modulates transcription and antagonist responses | Tamoxifen response, brain function |
| RARA | Retinoic acid receptor alpha; promoter activated by ERβ in response to tamoxifen | Breast cancer endocrine resistance |
| MAPK1 | ERK1; kinase in non-genomic estrogen signaling | Estrogen homeostasis, cell proliferation |
| MAPK3 | ERK2; kinase in non-genomic estrogen signaling | Estrogen homeostasis, cell proliferation |
| RPS6KA1 | RSK1; downstream effector of ERK1/2 in estrogen response | Regulation of estrogen homeostasis |
| RPS6KA2 | RSK2; downstream effector of ERK1/2 in estrogen response | Regulation of estrogen homeostasis |
| CYP19A1 | Aromatase; catalyzes estrogen biosynthesis | Endocrine disruption, breast cancer |
| ESRRA | Estrogen-related receptor alpha; modulates estrogen-like transcriptional programs | Metabolic regulation, cancer |
| PGR | Progesterone receptor; estrogen-regulated gene | Reproductive biology, breast cancer |
| GREB1 | Estrogen-regulated gene involved in proliferation | Breast cancer biomarker |
| TFF1 | Estrogen-inducible gene; marker of ER activity | Breast cancer research |
| CCND1 | Cyclin D1; estrogen-induced cell cycle regulator | Breast cancer proliferation |
| BCL2 | Anti-apoptotic protein regulated by estrogen | Breast cancer survival |
| VEGFA | Vascular endothelial growth factor; estrogen-regulated angiogenesis factor | Tumor angiogenesis |
| MMP2 | Matrix metalloproteinase 2; estrogen-modulated invasion factor | Cancer metastasis |
| IGF1 | Insulin-like growth factor 1; mediates estrogen effects on bone and growth | Osteoporosis, growth |
How Is response to estrogen Regulated?
Response to estrogen is regulated at multiple levels, including receptor availability, ligand synthesis, and post-translational modifications. ERK1/2-RSK signaling modulates estrogen homeostasis, and feedback loops control estrogen biosynthesis and receptor turnover. Additionally, environmental endocrine-disrupting chemicals can interfere with estrogen signaling and cause genomic instability.
response to estrogen and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ESR1 | Breast cancer, osteoporosis | Knockout and point-mutation cell lines [2,6] |
| ESR2 | Tamoxifen resistance, brain function | Overexpression and knockout models |
| MAPK1/MAPK3 | Estrogen homeostasis, proliferation | Knockout and knock-in for phospho-mutants |
| CYP19A1 | Endocrine disruption, breast cancer | Reporter assays and knockout |
| RARA | Breast cancer endocrine resistance | Promoter-reporter knock-in |
Breast Cancer
Luminal breast cancers are characterized by estrogen receptor positivity and depend on estrogen response for proliferation and survival. Spatial and single-cell transcriptomics have revealed molecular features of luminal breast cancer that reflect active estrogen signaling. Tamoxifen and other ER antagonists target this pathway, but resistance can occur through alternative activation of ERβ or other receptors.
Osteoporosis
Estrogen deficiency after menopause leads to increased bone resorption and osteoporosis. Estrogen response in bone cells regulates calcium homeostasis and response to edetic acid infusion, as shown in postmenopausal osteoporotic women. Understanding these mechanisms is key for developing bone-preserving therapies.
Neurodegeneration and Cognitive Decline
Estrogen influences hippocampal plasticity, with differential effects in young versus aged female rats. Age-related changes in estrogen response may contribute to cognitive decline and neurodegenerative diseases. Research into estrogen signaling in the brain is essential for developing interventions.
Endocrine Disruption and Genomic Instability
Exposure to environmental estrogen-like chemicals can disrupt normal estrogen responses and cause genomic instability. This has implications for cancer risk and reproductive health, highlighting the need for sensitive screening assays [3,8].
From response to estrogen-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does ESR1 mediate estrogen-dependent proliferation? | ESR1 knockout cell line (e.g., MCF-7) |
| How do point mutations in ESR1 affect ligand binding? | Point-mutation knock-in via CRISPR |
| What is the effect of ERβ overexpression on tamoxifen response? | Overexpression cell model |
| Can we track ERα dynamics in live cells? | Tagged knock-in (e.g., GFP-ESR1) |
| What genes are regulated by estrogen in bone cells? | RNA-seq after estrogen treatment in osteoblast-like cells |
| How does ERK1/2 signaling modulate estrogen homeostasis? | Knockout of MAPK1/3 or RSK isoforms |
How to Study the response to estrogen Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identifying estrogen-regulated genes |
| Single-cell RNA-seq | Cell-type-specific responses | Tumor heterogeneity in breast cancer |
| Spatial transcriptomics | Gene expression with tissue location | Luminal breast cancer features |
| Luciferase reporter assay | ER transcriptional activity | Screening (anti)estrogenic compounds |
| Western blot | Protein phosphorylation and expression | ERK/RSK signaling |
| Immunohistochemistry | Protein localization in tissues | ER expression in breast cancer |
| Behavioral tests | Cognitive function | Hippocampal plasticity in rats |
| Bone density measurement | Bone mineral density | Osteoporosis studies |
Transcriptomic Profiling
RNA-seq and single-cell RNA-seq can identify global gene expression changes in response to estrogen, revealing target genes and pathways. Spatial transcriptomics adds tissue context, as demonstrated in luminal breast cancer.
Reporter Assays and In Vitro Screening
Luciferase reporter assays driven by estrogen response elements (EREs) are used to screen for (anti)estrogenic activity of compounds, such as dipyrone. These assays quantify receptor activation and can be adapted for high-throughput screening.
Kinase Signaling Analysis
Western blotting and phospho-specific antibodies can measure activation of ERK1/2 and RSK in response to estrogen, linking non-genomic signaling to homeostasis. Inhibitor studies further dissect pathway contributions.
Animal Models and Behavioral Testing
Rodent models, including young and aged female rats, are used to study estrogen effects on hippocampal plasticity and behavior. Ovariectomy and hormone replacement mimic menopausal transitions [5,6].
How CRISPR Can Be Used to Study GO:0043627 response to estrogen
Knockout
CRISPR knockout of ESR1 or ESR2 in cell lines (e.g., MCF-7) abolishes estrogen response and can reveal essential genes for proliferation and survival. Knockout of MAPK1/3 or RSK isoforms clarifies non-genomic signaling contributions.
Point Mutation
Introducing point mutations in ESR1 (e.g., ligand-binding domain mutations) via CRISPR base editing or HDR can model endocrine resistance and test drug sensitivity. Such models help dissect the impact of specific residues on estrogen response.
Knock-in
Knock-in of tagged ESR1 (e.g., GFP or luciferase) allows live-cell imaging and tracking of receptor dynamics in response to estrogen. Knock-in of ERE-driven reporters enables sensitive quantification of transcriptional activity.
Overexpression
Overexpression of ESR2 or constitutively active mutants can mimic gain-of-function states and test their effects on tamoxifen response and gene expression. Overexpression models are useful for studying dose-dependent effects of estrogen signaling.
How EDITGENE Supports response to estrogen Research
Researchers studying response to estrogen-related genes often need to determine whether a candidate gene is causally involved in estrogen signaling, proliferation, or disease progression. EDITGENE provides custom CRISPR cell models and screening services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for response to estrogen research.
Frequently Asked Questions About response to estrogen
What is GO:0043627 response to estrogen?
GO:0043627 is a Gene Ontology biological process term describing any cellular or organismal change triggered by estrogen, a C18 steroid hormone.
What genes are involved in response to estrogen?
Key genes include ESR1, ESR2, MAPK1, MAPK3, RPS6KA1, RPS6KA2, and CYP19A1, among others [2,4,7].
How does estrogen signaling work?
Estrogen binds to estrogen receptors, which then regulate gene expression and activate rapid kinase cascades [4,7].
What diseases are linked to estrogen response?
Breast cancer, osteoporosis, cognitive decline, and endocrine disruption-related conditions [2,5,6,8].
What methods study response to estrogen?
RNA-seq, single-cell/spatial transcriptomics, reporter assays, Western blotting, and animal models [2,3,4,5].
How can CRISPR be used to study estrogen response?
CRISPR knockout, point mutation, knock-in, and overexpression models can test causal roles of genes in estrogen signaling [2,4,7].
What is the role of ERK1/2 in estrogen response?
ERK1/2 and RSK regulate estrogen homeostasis and mediate non-genomic estrogen signaling.
Is response to estrogen involved in breast cancer?
Yes, luminal breast cancers are driven by estrogen receptor signaling, and spatial transcriptomics has revealed molecular features.
How does estrogen affect bone?
Estrogen regulates bone remodeling and calcium homeostasis; deficiency leads to osteoporosis.
Can estrogen response be screened for endocrine disruptors?
Yes, in vitro reporter assays can screen compounds for (anti)estrogenic activity.
Conclusion
Response to estrogen (GO:0043627) is a multifaceted biological process with profound implications for health and disease. From genomic regulation to rapid signaling, estrogen orchestrates tissue-specific outcomes that are critical in cancer, bone metabolism, and neuroscience [2,4,5,6]. Leveraging CRISPR models and advanced omics, researchers can dissect the causal genes and pathways, paving the way for targeted therapies and personalized interventions [2,3,7].
References
- 1. Oosthuyse T et al.. 2010. The effect of the menstrual cycle on exercise metabolism: implications for exercise performance in eumenorrhoeic women.. Sports Med 40(3):207-27 PMID: 20199120
- 2. Yoshitake R et al.. 2024. Molecular features of luminal breast cancer defined through spatial and single-cell transcriptomics.. Clin Transl Med 14(1):e1548 PMID: 38282415
- 3. Passoni MT et al.. 2021. Uterotrophic and in vitro screening for (anti)estrogenic activity of dipyrone.. Toxicol Lett 352:1-8 PMID: 34536523
- 4. Wright EB et al.. 2023. ERK1/2-RSK regulation of oestrogen homeostasis.. FEBS J 290(8):1943-1953 PMID: 35176205
- 5. Adams MM et al.. 2001. Different modes of hippocampal plasticity in response to estrogen in young and aged female rats.. Proc Natl Acad Sci U S A 98(14):8071-6 PMID: 11427724
- 6. Cosman F et al.. 1994. Effects of estrogen on response to edetic acid infusion in postmenopausal osteoporotic women.. J Clin Endocrinol Metab 78(4):939-43 PMID: 8157725
- 7. Zou A et al.. 1999. Estrogen receptor beta activates the human retinoic acid receptor alpha-1 promoter in response to tamoxifen and other estrogen receptor antagonists, but not in response to estrogen.. Mol Endocrinol 13(3):418-30 PMID: 10076999
- 8. Roy D et al.. 1998. Is exposure to environmental or industrial endocrine disrupting estrogen-like chemicals able to cause genomic instability?. Front Biosci 3:d913-21 PMID: 9696883
